Vaccination of healthcare personnel: Spotlight on groups with underlying conditions

Vaccine

Volumn 32, Issue 32, 2014, Pages 4025-4031

  Wicker, Sabine ^a   Seale, Holly ^b   Von Gierke, Laura ^a   Maltezou, Helena ^c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

Healthcare personnel; Healthcare worker; Immunization; Immunocompromised; Occupational infections; Vaccination

Indexed keywords

CHICKENPOX VACCINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MATERNAL ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

2009 H1N1 INFLUENZA; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; ATTRIBUTABLE RISK; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; DISEASE SEVERITY; FATALITY; FEVER; GRAFT RECIPIENT; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MEASLES; MORBIDITY; MORTALITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL PHYSICIAN; OCCUPATIONAL SAFETY; PANDEMIC; PERTUSSIS; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RUBELLA; SEASONAL INFLUENZA; SEROCONVERSION; THIRD TRIMESTER PREGNANCY; VACCINATION; VIRUS LOAD; AGED; CONTRAINDICATIONS; CROSS INFECTION; FEMALE; HEALTH CARE POLICY; OCCUPATIONAL HEALTH; PREGNANCY; STANDARDS;

AGED; CROSS INFECTION; FEMALE; HEALTH PERSONNEL; HEALTH POLICY; HUMANS; IMMUNOCOMPROMISED HOST; OCCUPATIONAL HEALTH; PREGNANCY; VACCINATION; VACCINES;

EID: 84902548480     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.070     Document Type: Article

References (75)

1. van Panhuis W.G., Grefenstette J., Jung S.Y., Chok N.S., Cross A., Eng H., et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med 2013, 369:2152-2158.
2. Sepkowitz K.A. Occupationally acquired infections in health care workers. Part I. Ann Intern Med 1996, 125:826-834.
3. Sepkowitz K.A. Occupationally acquired infections in health care workers. Part II. Ann Intern Med 1996, 125:917-928.
4. Maltezou H.C., Poland G.A. Vaccination policies for healthcare workers in Europe. Vaccine 2013, [October 23, Epub ahead of print].
5. Facanha M.C., Monroe A.C. Occupational and nosocomial transmission of varicella. Braz J Infect Dis 2006, 10:156-158.
6. Steingart R.K., Thomas R.A., Dykewicz A.C., Redd C.S. Transmission of measles virus in healthcare settings during a communitywide outbreak. Infect Control Hosp Epidemiol 1999, 20:115-119.
7. Prüss-Üstun A.A., Rapiti E., Hutin Y. Estimation of the global burden of disease attributable to contaminated sharp injuries among health-care workers. Am J Ind Med 2005, 48:482-490.
8. Fiebelkorn A.P., Seward J.F., Orenstein W. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine 2013, [Epub ahead of print].
9. Kuster S.P., Shah P.S., Coleman B.L., Lam P.P., Tong A., Wormsbecker A., et al. Incidence of influenza in healthy adults and healthcare workers: A systematic review and meta-analysis. PLoS ONE 2011, 6(10):e26239.
10. Maltezou H.C., Ftika L., Theodoridou M. Nosocomial pertussis in neonatal units. J Hosp Infect 2013, 85:243-248.
11. Kellie S.M., Makvandi M., Mullet M.L. Management and outcome of a varicella exposure in a neonatal intensive care unit: lessons for the vaccine era. Am J Infect Control 2011, 39:844-848.
12. Heseltine P.N., Ripper M., Wohlford P. Nosocomial rubella: consequences of an outbreak and efficacy of a mandatory immunization program. Infect Control 1985, 6:371-374.
13. Carlson A.L., Perl T.M. Health care workers as source of hepatitis B and C virus transmission. Clin Liver Dis 2010, 14:153-168.
14. Doebbeling B.N., Li N., Wenzel R.P. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health 1993, 83:1679-1684.
15. Maltezou H.C. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008, 21:337-343.
16. Maltezou H.C., Wicker S. Measles in health care settings. Am J Infect Control 2013, 41:661-663.
17. Talbot T.R. Update on immunizations for healthcare personnel in the United States. Vaccine 2013, [Epub ahead of print].
18. Centers for Disease Control and Prevention Immunization of health-care personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011, 60:1-45.
19. Weber D.J., Rutala W.A. Vaccines for health care personnel. Vaccines 2013, 1290-1307. 6th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
20. Maltezou H.C., Wicker S., Borg M., Heininger U., Puro V., Theodoridou M., et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine 2011, 29:9557-9562.
21. National Health & Medical Research Council The Australian immunisation handbook 2013, Australian Government Publishing Service, Canberra. 10th ed.
22. World Health Organization Health topics: chronic diseases 2014, Available at: http://www.who.int/topics/chronic_diseases/en [last assessed 19.02.14].
23. Centers for Disease Control and Prevention Chronic diseases and health promotion 2014, Available at: http://www.cdc.gov/chronicdisease/overview/index.htm [last 19.02.14].
24. International Labor Organization (ILO) An ILO code of practice on HIV/AIDS and the world of work 2001, Available at: http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/publication/wcms_113783.pdf [last assessed 19.02.14].
25. World Health Organization Data and statistics - dynamic health labour markets in the European region 2014, Available at: http://www.euro.who.int/en/health-topics/Health-systems/health-workforce/data-and-statistics [last assessed 19.02.14].
26. Rubin L.G., Levin M.J., Ljungman P., Davies E.G., Avery R., Tomblyn M., et al. IDSA Clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014, 58:309-318.
27. Centers for Disease Control and Prevention Surveillance of occupationally acquired HIV/AIDS in healthcare personnel, as of December 2010 2011, Available at: http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html [last assessed 19.02.14].
28. Molton J., Smith C., Chaytor S., Maple P., Brown K., Johnson M., et al. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. J Infection 2010, 61:73-80.
29. Moss W.J., Sutcliffe C.G., Halsey N.A. Vaccination of human immunodeficiency virus-infected persons. Vaccines 2013, 1257-1267. 6th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
30. Centers for Disease Control and Prevention (CDC) Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. MMWR 2009, 58(RR-11):1-167.
31. Centers for Disease Control and Prevention Fact sheet: BCG vaccine 2011, Available at: http://www.cdc.gov/tb/publications/factsheets/prevention/bcg.htm [last accessed 19.02.14].
32. Centers for Disease Control and Prevention (CDC) Use of 13-valentpneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2012, 61:816-819.
33. Kim H.N., Harrington R.D., Crane H.M., Dhanireddy S., Dellit T.H., Spach D.H., et al. Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations. Int J STD AIDS 2009, 9:595-600.
34. Fonseca M.O., Pang L.W., de Paula Cavalheiro N., Barone A.A., Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005, 23:2902-2908.
35. Robert Koch-Institut Recommendations of the Standing Committee on Vaccinations (STIKO) 2013, Available at: http://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2013/Ausgaben/34_13.pdf?__blob=publicationFile [last assessed 19.02.14].
36. Bickel M., Lassmann C., Wieters I., Doerr H.W., Herrman E., Wicker S., et al. Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1 infected patients and healthy controls. HIV Clinical Trials 2013, 14:175-184.
37. Atashili J., Kalilani L., Adimora A.A. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 2006, 11(6:):138.
38. Cheeseman S.H., Davaro R.E., Ellison R.T., Hepatitis B vaccination and plasma HIV-1 RNA. New Engl J Med 1996, 334:1272.
39. Skiest D.J., Machala T. Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol 2003, 26:307-315.
40. Yerly S., Wunderli W., Wyler C.A., Kaiser L., Hirschel B., Suter S., et al. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. AIDS 1994, 10:1503-1504.
41. Ljungman P. Vaccination of immunocompromised hosts. Vaccines 2013, 1243-1256. 6th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
42. Löbermann M., Borso D., Hilgendorf I., Fritzsche C., Zettl U.K., Reisinger E.C. Immunization in the adult immunocompromised host. Autoimmun Rev 2012, 11:212-218.
43. Kamboj M., Sepkowitz K.A. Nosocomial infections in patients with cancer. Lancet Oncol 2009, 10:589-597.
44. National Comprehensive Cancer Network (NCCN) NCCN clinical practice guidelines in oncology survivorship 2013, Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp [last assessed 19.02.14].
45. Centers for Disease Control and Prevention Work place safety and health topics. Healthcare worker 2014, Available at: http://www.cdc.gov/niosh/topics/healthcare/ [last assessed 19.02.14].
46. Kaplan L.J., Daum R.S., Smaron M., McCarthy C.A. Severe measles in immunocompromised patients. JAMA 1992, 267:1237-1241.
47. Bingham C.O. Vaccination for patients with rheumatic diseases 2013, Available at: http://www.rheumatology.org [last assessed 19.02.14].
48. Singh J.A., Furst D.E., Bharat A., Curtis J.R., Kavanaugh A.F., Kremer J.M., et al. 2012 Update of the 2008 American College of Rheumatology Recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012, 64:625-639.
49. Goldacker S., Gause A.M., Warnatz K. Kommission Pharmakotherapie der DGRH. Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 2013, 72:690-704.
50. Cihan F.G., Durmaz F.G., Odabas D., Baydemir C., Fatma K. Attitudes toward and factors affecting influenza vaccination among physicians and nurses of a tertiary-care hospital in Central Anatolia region of Turkey. Postgrad Med 2012, 124:117-123.
51. Toh M.P., Kannan P., Chen Y., Chng F.L., Tang W.E. Healthcare workers and H1N1 vaccination: does having a chronic disease make a difference. Vaccine 2012, 30:1064-1070.
52. Mertz D., Kim T.H., Johnstone J., Lam P.P., Science M., Kuster S.P., et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013, 347:f5061.
53. Udell J.A., Zawi R., Bhatt D.L., Keshtkar-Jahromi M., Gaughran F., Phrommintikul A., et al. association between influenza vaccination and cardiovascular outcomes in High-risk patients. A meta-analysis. JAMA 2013, 310:1711-1720.
54. Habib S., Rishpon S., Rubin L. Influenza vaccination among healthcare workers. IMAJ 2000, 2:899-901.
55. SočanM.Erčulj V., Lajovic J. Knowledge and attitudes on pandemic and seasonal influenza vaccination among Slovenian physicians and dentists. Eur J Public Health 2013, 23:92-97.
56. Kwetkat A., Pletz M.W. Vaccination in the elderly. Z Gerontol Geriat 2013, 46:673-681.
57. Grubeck-Loebenstein B., Della Bella S., Iorio A.M., Michel J.P., Pawelec G., Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009, 21:201-209.
58. Gusmano M.K., Michel J.P. Life course vaccination and healthy aging. Aging Clin Exp Res 2009, 21:258-263.
59. Poland G.A., Belmin J., Langley J., Michel J.P., Van Damme P., Wicker S. A global prescription for adult immunization: time is catching up with us. Vaccine 2010, 28:7137-7139.
60. Gall S.A., Poland G.A. A maternal immunization program (MIP). Developing a schedule and platform for routine immunization during pregnancy. Vaccine 2011, 29:9411-9413.
61. Goins W.P., Schaffner W., Edwards K.M., Talbot T.R. Healthcare workers' knowledge and attitudes about pertussis and pertussis vaccination. Infect Control Hosp Epidemiol 2007, 28:1284-1289.
62. Cherry J.D. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367:785-787.
63. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child 2013, 98:552-555.
64. Centers for Disease Control and Prevention (CDC) 2014 Recommended Immunizations for adults by medical conditions 2014, Available at: http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule-easy-read-bw.pdf [last assessed 19.02.14].
65. Sawyer M., Liang J.L., Clark T.A. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women - advisory committee on immunization practices (ACIP), 2012. MMWR 2013, 62:131-135.
66. Terranella Asay B., Messonnier M.L., Clark T.A., Liang J.L. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013, 131:e1748-e1756.
67. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(334):e1-e5.
68. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
69. Eppes C., Wu A., You W., Cameron K.A., Grobman W. Barriers to influenza vaccination among pregnant women. Vaccine 2013, 31:2874-2878.
70. Steinhoff M.C. Assessments of vaccines for prenatal immunization. Vaccine 2013, 31S(1):D27-D30.
71. Sage Working Group Background paper on influenza vaccines and immunization 2012, Available at: http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf [last assessed 19.02.14].
72. Wong V.W.Y., Fong D.Y.T., Tarrant M. Brief education to increase uptake of influenza vaccine among pregnant women: a study protocol for a randomized controlled trial. BMC Preg. Childbirth 2014, 14:19.
73. Blondel B., Mahjoub N., Drewniak N., Launay O., Goffinet F. Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey. Vaccine 2012, 30:5661-5665.
74. Luteijn J.M., Dolk H., Marnoch G.J. Differences in pandemic influenza vaccination policies for pregnant women in Europe. BMC Public Health 2011, 11:819.
75. Howland R., Lu E. Influenza vaccination among pregnant women - Massachusetts, 2009-2010. MMWR 2013, 43:854-857.